| ACT's Dr. Robert Lanza to Deliver Keynote Lecture at the World Conference on Regenerative Medicine | MARLBOROUGH, Mass.--(BUSINESS WIRE)--October 21, 2013--
Advanced Cell Technology, Inc. ("ACT"; OTCBB:ACTC), a leader in the field of regenerative medicine, announced today that its chief scientific officer, Robert Lanza, M.D., will be delivering a Keynote lecture at the "World Conference on Regenerative Medicine" being held in Leipzig, Germany October 23-25th. The Conference is considered one of the world's largest and most influential events in stem cells and regenerative medicine, and provides a platform that brings scientists with an academic, clinical and industrial background together. Dr. Lanza's Lecture, entitled "ES and iPS Cells -- Moving into the Clinic," will take place at 9:00 a.m. at the Congress Center Leipzig.
The World Conference will, as in past years, encompass a broad range of topics in regenerative medicine from biomaterials to biomarkers as well as regulation and stem cell technologies. The organizers expect more than 1,000 attendees and hundreds of papers with ground-breaking scientific insights and new results. Furthermore, the conference will host a large exhibition where international researchers and biotechnology companies can demonstrate the reach of current technology's translation and the implementation of research in products. In addition to Dr. Lanza's Keynote Lecture, the Conference will include presentations on cell and immunotherapy, stem cells, cell and tissue engineering, biomaterials and tissue interaction, models of regeneration, molecular mechanisms of regeneration, diagnostic and imaging of regeneration, and regulatory affairs. |
